Skip Navigation


Rheumatology Advance Access originally published online on July 2, 2009
Rheumatology 2009 48(9):1102-1106; doi:10.1093/rheumatology/kep149
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
48/9/1102    most recent
kep149v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Reksten, T. R.
Right arrow Articles by Brokstad, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reksten, T. R.
Right arrow Articles by Brokstad, K. A.
Related Collections
Right arrow Sjogren's Syndrome
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome

Tove R. Reksten1,*, Malin V. Jonsson1,2,*, Ewa A. Szyszko1, Johan G. Brun2,3, Roland Jonsson1,3 and Karl A. Brokstad1

1Broegelmann Research Laboratory, The Gade Institute, 2Institute of Medicine – Section for Rheumatology, University of Bergen and 3Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.

Correspondence to: Tove R. Reksten, Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Haukelandsveien 28, N-5021 Bergen, Norway. E-mail: tove.reksten{at}gades.uib.no


   Abstract

Objective. To investigate a potential correlation between circulating cytokine and autoantibody levels and histopathological features in subgroups of patients with primary SS (pSS).

Methods. Minor salivary gland biopsies from a cohort of 141 patients fulfilling the American–European consensus classification criteria for pSS were re-examined and grouped according to focus score (FS) and germinal centre (GC) status; serum samples were analysed for autoantibodies, chemokines and cytokines.

Results. Of the 115 available biopsies, 18 (16%) lacked characteristic focal mononuclear cell infiltrates [FS < 1 (FS–)] but patients were positive for Ro/SSA and/or La/SSB. IL-17, IL-1RA, IL-15, macrophage inflammatory protein (MIP)-1{alpha}, MIP-1β, eotaxin, IFN-{alpha} and IL-4 levels were significantly increased in the 27 (23%) patients with ectopic GC formation (GC+) in the salivary glands compared with the GC– patients (n = 70). In addition, minor differences in cytokine levels were found when comparing age groups.

Conclusion. Degenerative changes observed in the minor salivary glands of patients with pSS may represent ‘burned out’ inflammation. The elevated levels of IL-4 found in these patients may influence the reduced salivary flow observed in GC+ patients. Increased titres of Th17-associated cytokines, IL-17, IL-1β and the IL-23 subunit IL-12p40, may indicate a higher activity of these cells in GC+ patients. Differences in cytokine levels may be utilized when sub-grouping the SS patients into disease phases and may consequently have implications for treatment.

KEY WORDS: Adiopocytes, Atrophy, Autoantibodies, Cytokines, Degenerative changes, Fibrosis, Inflammation, Salivary glands


*Tove R. Reksten and Malin V. Jonsson equally contributed to this work.

Submitted 3 February 2009; revised version accepted 12 May 2009.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.